Cinclus Pharma Holding AB (publ) (STO:CINPHA)
11.82
0.00 (0.00%)
At close: Aug 14, 2026
Cinclus Pharma Holding AB Revenue
Cinclus Pharma Holding AB had revenue of 10.04M SEK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 67.51M, up 1,373.93% year-over-year. In the year 2025, Cinclus Pharma Holding AB had annual revenue of 57.47M with 1,154.80% growth.
Revenue (ttm)
67.51M
Revenue Growth
+1,373.93%
P/S Ratio
8.15
Revenue / Employee
3.97M
Employees
17
Market Cap
550.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.47M | 52.89M | 1,154.80% |
| Dec 31, 2024 | 4.58M | -1.38M | -23.14% |
| Dec 31, 2023 | 5.96M | -4.61M | -43.63% |
| Dec 31, 2022 | 10.57M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.35M |
| Cereno Scientific AB | 66.82M |
| Nanexa AB | 54.41M |
| Enzymatica AB | 51.93M |
| Newbury Pharmaceuticals AB | 35.02M |
| Moberg Pharma AB | 16.76M |
| Orexo AB | 16.60M |
| Enorama Pharma AB | 2.18M |
Cinclus Pharma Holding AB News
- 2 months ago - Cinclus Pharma Holding AB Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Cinclus Pharma Holding AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Cinclus Pharma Holding AB Slides: Q1 2026 - Filings
- 6 months ago - Cinclus Pharma Holding AB Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Cinclus Pharma Holding AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Cinclus Pharma Holding AB Slides: Q4 2025 - Filings
- 6 months ago - Cinclus Pharma Holding AB Annual report: Q4 2025 - Filings